Cleared Special

TracStar LDP Large Distal Platform (K231168) - FDA 510(k) Clearance

Also marketed or referenced as:
Zoom 88 Large Distal Platform Zoom 88 Large Distal Platform Support

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K231168 · Imperative Care, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
27d
Days
Class 2
Risk

K231168 is an FDA 510(k) clearance for the TracStar LDP Large Distal Platform. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Imperative Care, Inc. (Campbell, US). The FDA issued a Cleared decision on May 22, 2023 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Imperative Care, Inc. devices

Submission Details

510(k) Number K231168 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2023
Decision Date May 22, 2023
Days to Decision 27 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
121d faster than avg
Panel avg: 148d · This submission: 27d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K231168.
Plato 17 Microcatheter
K223560 · Scientia Vascular, Inc. · Aug 2023
Route 92 Medical Full Length 054 Access System
K231583 · Route 92 Medical, Inc. · Aug 2023
SelectFlex Neurovascular Access System Family
K230322 · Q'Apel Medical, Inc. · Jun 2023
CEREGLIDE 71 Intermediate Catheter
K221930 · Cerenovus, Inc. · Mar 2023
CELLO II Balloon Guide Catheter
K223275 · Fuji Systems Corporation · Dec 2022
BENCHMARK BMX81 Access System
K221822 · Penumbra, Inc. · Nov 2022